Crossmark

Intravenous combined with nebulized polymyxin B may be effective in treating carbapenem-resistant gram-negative bacilli hospital-acquired pneumonia: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1007/s10096-025-05208-3

Published Online: 2025-07-09

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Ye

Chen, Jiangtao

Fang, Lexin

Wang, Min

Zeng, Wenqing

Ding, Yueping
License Information

Text and Data Mining valid from 2025-07-09

Version of Record valid from 2025-07-09
More Information

Article History

Received: 3 March 2025

Accepted: 1 July 2025

First Online: 9 July 2025

Declarations

:

: The study protocol was approved by the Ethics Review Committee of The Second Affiliated Hospital of Zhejiang Chinese Medical University (Approval No. ZJTCMU2AE2023R081-01).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below